ABT530
ABT-530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6.
| Catalog Number | T5127 |
| Alternative Name(s) | ABT 530 , Pibrentasvir , ABT-530 |
| Research Area | Proteases/Proteasome|||Microbiology/Virology |
| Molecular Formula | C57H65F5N10O8 |
| CAS# | 1353900-92-1 |
| SMILES | CO[C@H](C)[C@H](NC(=O)OC)C(=O)N1CCC[C@H]1c1nc2cc(F)c(cc2[nH]1)[C@H]1CC[C@@H](N1c1cc(F)c(N2CCC(CC2)c2ccc(F)cc2)c(F)c1)c1cc2[nH]c(nc2cc1F)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/ABT530 |
| Additional Information | https://www.targetmol.com/datasheet/T5127 |